Proactive Consultation by a Clinical Pathologist Prevents Diagnostic Delay in Hematological Malignancies |
Chang, Chih-Chun
(Department of Clinical Pathology, Far Eastern Memorial Hospital)
Su, Ming-Jang (Department of Clinical Pathology, Far Eastern Memorial Hospital) Ho, Jung-Li (Department of Clinical Pathology, Far Eastern Memorial Hospital) Sun, Jen-Tang (Department of Emergency, Far Eastern Memorial Hospital) Tsai, Huang-Wen (Department of Surgery, Far Eastern Memorial Hospital) Tang, Hui-Fei (Department of Clinical Pathology, Far Eastern Memorial Hospital) Chu, Fang-Yeh (Department of Clinical Pathology, Far Eastern Memorial Hospital) |
1 | Abdel-Rahman M, Stockton D, Rachet B, et al (2009). What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? Br J Cancer, 101, 115-24. DOI |
2 | Elliss-Brookes L, McPhail S, Ives A, et al (2012). Routes to diagnosis for cancer - determining the patient journey using multiple routine data sets. Br J Cancer, 107, 1220-26. DOI |
3 | Friese CR, Abel GA, Magazu LS, et al (2009). Diagnostic delay and complications for older adults with multiple myeloma. Leuk Lymphoma, 50, 392-400. DOI |
4 | Howell DA, Smith AG, Roman E (2008). Help-seeking behaviour in patients with lymphoma. Eur J Cancer Care, 17, 394-403. DOI |
5 | Howell DA, Smith AG, Jack A, et al (2013). Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network. BMC Hematol, 13, 9. DOI |
6 | Irfan SM, Bhurgri Y (2009). Clinico-pathological features and outcomes in chronic phase chronic myeloid leukemia patients treated with hydroxyurea. Asian Pac J Cancer Prev, 10, 591-94. |
7 | Kariyawasan CC, Hughes DA, Jayatillake MM, et al (2007). Multiple myeloma: causes and consequences of delay in diagnosis. QJM, 100, 635-40. DOI |
8 | Kuwajima M (1997). Clinical laboratory consultation in the general hospital. Rinsho Byori, 45, 727-31. |
9 | Kuwajima M (1998). Active laboratory consultation for the clinical supporting system in the general hospital. Rinsho Byori, 46, 994-8. |
10 | Kyle RA, Gertz MA, Witzig TE, et al (2003). Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc, 78, 21-33. DOI |
11 | Lyratzopoulos G, Neal RD, Barbiere JM, et al (2012). Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 national cancer patient experience survey in England. Lancet Oncol, 13, 353-65. DOI |
12 | Lyratzopoulos G, Abel GA, McPhail S, et al (2013). Measures of promptness of cancer diagnosis in primary care: secondary analysis of national audit data on patients with 18 common and rarer cancers. Br J Cancer, 108, 686-90. DOI |
13 | Summerfield GP, Carey PJ, Galloway MJ, et al (2000). An audit of delays in diagnosis and treatment of lymphoma in district hospitals in the northern region of the United Kingdom. Clin Lab Haematol, 22, 157-60. DOI |
14 | Mai Y, Qi P, Xu Y, et al (2007). Clinical and laboratory features of newly diagnosed multiple myeloma: a retrospective, single-centre analysis. Chin Med J, 120, 1727-9. |
15 | Burke MD (1995). Clinical laboratory consultation. Clin Chem, 41, 1237-40. |
16 | Ong F, Hermans J, Noordijk EM, et al (1995). Presenting signs and symptoms in multiple myeloma: high percentages of stage III among patients without apparent myeloma-associated symptoms. Ann Hematol, 70, 149-52 DOI |
17 | Thomson CS, Forman D (2009). Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results? Br J Cancer, 101, 102-9. DOI |